Advertisement

Topics

TiGenix gets exclusive rights to mesenchymal stem cell IP from Mesoblast

14:40 EST 19 Dec 2017 | Elsevier Business Intelligence

Mesoblast Ltd. granted TiGenix NV exclusive rights to patents surrounding the use of adipose-derived mesenchymal stem cells t...

Original Article: TiGenix gets exclusive rights to mesenchymal stem cell IP from Mesoblast

NEXT ARTICLE

More From BioPortfolio on "TiGenix gets exclusive rights to mesenchymal stem cell IP from Mesoblast"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...